280 related articles for article (PubMed ID: 20689964)
1. Intravitreal bevacizumab injection for persistent serous retinal detachment associated with Vogt-Koyanagi-Harada disease.
Park HS; Nam KY; Kim JY
Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):133-6. PubMed ID: 20689964
[TBL] [Abstract][Full Text] [Related]
2. Treatment of persistent serous retinal detachment in Vogt-Koyanagi-Harada syndrome with intravitreal bevacizumab during the systemic steroid treatment.
Reibaldi M; Russo A; Avitabile T; Uva MG; Franco L; Longo A; Toro MD; Cennamo G; Mariotti C; Neri P; Noci ND; Russo V
Retina; 2014 Mar; 34(3):490-6. PubMed ID: 23903795
[TBL] [Abstract][Full Text] [Related]
3. [Vogt-Koyanagi-Harada syndrome in children - a case report].
Bušányová B; Tomčíková D; Gerinec A
Cesk Slov Oftalmol; 2013 Jun; 69(2):81-6. PubMed ID: 23964873
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration.
el Matri L; Chebil A; Kort F; Bouraoui R; Baklouti K; Mghaieth F
Graefes Arch Clin Exp Ophthalmol; 2010 Jun; 248(6):779-84. PubMed ID: 20169357
[TBL] [Abstract][Full Text] [Related]
5. Rebound inflammation after an intravitreal injection in Vogt-Koyanagi-Harada syndrome.
Ranjan R; Agarwal M
Indian J Ophthalmol; 2018 Jun; 66(6):863-865. PubMed ID: 29786006
[TBL] [Abstract][Full Text] [Related]
6. Choroidal Detachment following an Intravitreal Injection in a Patient with Vogt-Koyanagi- Harada Disease.
Kumar N; Rana N; Bansal R
Ocul Immunol Inflamm; 2021 Feb; 29(2):396-398. PubMed ID: 31664881
[No Abstract] [Full Text] [Related]
7. Outcomes of Anti-vascular Endothelial Growth Factor Treatment for Foveal Serous Retinal Detachment Associated with Inferior Staphyloma.
Lee EK; Yu HG
Korean J Ophthalmol; 2019 Jun; 33(3):228-237. PubMed ID: 31179654
[TBL] [Abstract][Full Text] [Related]
8. One-year results of combined photodynamic therapy and intravitreal bevacizumab injection for retinal pigment epithelial detachment secondary to age-related macular degeneration.
Shima C; Gomi F; Sawa M; Sakaguchi H; Tsujikawa M; Tano Y
Graefes Arch Clin Exp Ophthalmol; 2009 Jul; 247(7):899-906. PubMed ID: 19308441
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal bevacizumab for treatment of serous macular detachment in central retinal vein occlusion.
Cinal A; Ziemssen F; Bartz-Schmidt KU; Gelisken F
Graefes Arch Clin Exp Ophthalmol; 2011 Apr; 249(4):513-20. PubMed ID: 21053008
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab for choroidal neovascularization secondary to Vogt-Koyanagi-Harada syndrome.
Wu L; Evans T; Saravia M; Schlaen A; Couto C
Jpn J Ophthalmol; 2009 Jan; 53(1):57-60. PubMed ID: 19184312
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab in the management of subretinal fluid associated with choroidal osteoma.
Song JH; Bae JH; Rho MI; Lee SC
Retina; 2010 Jun; 30(6):945-51. PubMed ID: 20531145
[TBL] [Abstract][Full Text] [Related]
12. Treatment of macular serous neuroretinal detachment in tilted disk syndrome: report of 3 cases.
Donati MC; Miele A; Abbruzzese G; Giuntoli M; Giansanti F; Menchini U
Eur J Ophthalmol; 2013; 23(2):267-70. PubMed ID: 23225087
[TBL] [Abstract][Full Text] [Related]
13. Effect of intravitreal bevacizumab based on optical coherence tomography patterns of diabetic macular edema.
Kim M; Lee P; Kim Y; Yu SY; Kwak HW
Ophthalmologica; 2011; 226(3):138-44. PubMed ID: 21822008
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab injection in a 14-year-old Vogt-Koyanagi-Harada patient with choroidal neovascular membrane.
Raffa L; Bawazeer A
Can J Ophthalmol; 2009 Oct; 44(5):615-6. PubMed ID: 19789612
[No Abstract] [Full Text] [Related]
15. Intravitreal Bevacizumab for Traumatic Choroidal Rupture.
Kim M; Kim JH; Seo Y; Koh HJ; Lee SC
Optom Vis Sci; 2015 Oct; 92(10):e363-7. PubMed ID: 26367340
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab for treatment-naïve subfoveal occult choroidal neovascularization in age-related macular degeneration.
Furino C; Boscia F; Recchimurzo N; Besozzi G; Cardascia N; Sborgia L; Niro A; Sborgia C
Acta Ophthalmol; 2009 Jun; 87(4):404-7. PubMed ID: 18782335
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal triamcinolone acetonide in Vogt-Koyanagi-Harada syndrome.
Karacorlu M; Arf Karacorlu S; Ozdemir H
Eur J Ophthalmol; 2006; 16(3):481-3. PubMed ID: 16761256
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
Andrade RE; Muccioli C; Farah ME; Nussenblatt RB; Belfort R
Am J Ophthalmol; 2004 Mar; 137(3):572-4. PubMed ID: 15013890
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration.
Ach T; Hoeh AE; Ruppenstein M; Kretz FT; Dithmar S
Retina; 2010 Oct; 30(9):1420-5. PubMed ID: 20543764
[TBL] [Abstract][Full Text] [Related]
20. [Retinal angiomatous proliferation with associated pigment epithelium detachment: anti-VEGF therapy].
Lommatzsch A; Heimes B; Gutfleisch M; Spital G; Dietzel M; Pauleikhoff D
Ophthalmologe; 2011 Mar; 108(3):244-51. PubMed ID: 20571805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]